Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum neurotoxin A: an unusual systemic effect.

Katherine Howell1, Paulo Selber, H Kerr Graham

  • 1Department of Child Development and Rehabilitation, Royal Children's Hospital, Parkville, Victoria, Australia.

Journal of Paediatrics and Child Health
|May 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote Sensing Enables Basin-Scale Inventories of Coal Mine Methane.

Environmental science & technology·2026
Same author

Intraoperative Hip Arthrography to Guide Decision-Making in Cerebral Palsy Hip Reconstruction.

Journal of pediatric orthopedics·2026
Same author

The Spinal Muscular Atrophy Functional Classification System.

Developmental medicine and child neurology·2026
Same author

Prophylactic antibiotics to prevent chest infections in children with neurological impairment: the PARROT RCT.

Health technology assessment (Winchester, England)·2026
Same author

The role of the popliteal angle as an indicator for hamstring lengthening to treat a flexed knee gait in children with cerebral palsy: A systematic review.

Journal of children's orthopaedics·2025
Same author

Spinopelvic alignment and sagittal gait kinematics of adult patients with cerebral palsy.

Spine deformity·2025

Systemic effects from Botulinum neurotoxin A are rare but serious. In a child with cerebral palsy, it caused respiratory and oromotor decline, highlighting treatment caution.

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Background:

  • Botulinum neurotoxin A is widely used for spasticity.
  • Systemic adverse events are considered uncommon.
  • Cerebral palsy presents significant management challenges.

Observation:

  • A pediatric patient with severe cerebral palsy received repeated Botulinum neurotoxin A injections.
  • The patient experienced a decline in respiratory and oromotor functions post-treatment.

Findings:

  • This case suggests a potential link between Botulinum neurotoxin A injections and systemic effects.
  • Deterioration in respiratory and oromotor function was observed.

Implications:

  • Caution is advised when administering Botulinum neurotoxin A to children with severe cerebral palsy.

Related Experiment Videos

  • Consideration of pseudobulbar palsy in conjunction with cerebral palsy is important.
  • Further research into the systemic effects of Botulinum neurotoxin A in pediatric populations is warranted.